Platelet transfusion for patients with cancer

Area of Science:

• Oncology
• Hematology
• Transfusion Medicine

Background:

• Platelet transfusions are essential for managing bleeding complications in cancer patients.
• Cancer therapies can decrease platelet counts, increasing bleeding risks.
• Allogeneic platelet transfusions aid hemostasis but alloimmunization can complicate management.

Purpose of the Study:

• To review the literature on platelet transfusion in cancer patients.
• To highlight essential knowledge for healthcare professionals regarding platelet transfusions in oncology.

Main Methods:

• Literature review on platelet transfusion in cancer patients.

Main Results:

• Key topics include platelet storage, dosing, transfusion indications, and response assessment.
• Differentiating immune-mediated from non-immune-mediated platelet refractoriness is crucial for tailored management.
• Understanding these aspects is vital for healthcare professionals managing cancer patients requiring transfusions.

Conclusions:

• Effective patient care requires optimal platelet inventory utilization and laboratory testing.
• Clear communication between oncology teams and blood product providers is essential.
• Appropriate management strategies are vital for patients with cancer undergoing treatment.